American Joint Committee on Cancer

American Joint Committee on Cancer
Name	American Joint Committee on Cancer
Abbreviation	AJCC
Formation	1959
Type	Nonprofit
Headquarters	Chicago, Illinois
Region served	United States
Leader title	Chair

American Joint Committee on Cancer is a multidisciplinary committee that develops cancer staging systems used by clinicians, researchers, and policymakers. It collaborates with medical societies, academic institutions, and international organizations to standardize tumor classification, prognostic assessment, and treatment decision frameworks. Its staging manuals inform clinical trials, registries, and public health initiatives across oncology, surgery, radiology, and pathology.

History

The committee traces its roots to collaborations among American College of Surgeons, National Cancer Institute, International Union Against Cancer, Memorial Sloan Kettering Cancer Center, and specialist societies such as American Society of Clinical Oncology and Society of Surgical Oncology. Early influences included staging efforts at Johns Hopkins Hospital, Mayo Clinic, Massachusetts General Hospital, and work by pathologists affiliated with University of Pennsylvania and Columbia University Irving Medical Center. Milestones involved input from figures associated with Roswell Park Comprehensive Cancer Center, St. Jude Children's Research Hospital, Dana-Farber Cancer Institute, and researchers at Stanford University School of Medicine and Harvard Medical School. Major editions of staging manuals were shaped through conferences held at venues like Cleveland Clinic, NewYork-Presbyterian Hospital, University of California, San Francisco, and international meetings with delegates from Royal College of Surgeons, European Society for Medical Oncology, World Health Organization, and International Agency for Research on Cancer.

Organization and Governance

Governance structures reflect representation from professional organizations including American College of Radiology, College of American Pathologists, American Board of Surgery, American Board of Radiology, and specialist groups such as American Head and Neck Society and American Society of Radiation Oncology. Leadership positions have been held by clinicians and scientists affiliated with institutions like Yale School of Medicine, University of Chicago Medicine, University of Michigan Medical School, University of Texas MD Anderson Cancer Center, and Northwestern University Feinberg School of Medicine. Committees and task forces draw members nominated by bodies such as American Cancer Society, Association of American Medical Colleges, Canadian Cancer Society, and research networks including Alliance for Clinical Trials in Oncology and Children's Oncology Group. Administrative support interacts with entities like Centers for Disease Control and Prevention and registry partners such as Surveillance, Epidemiology, and End Results Program.

TNM Staging System Development

The committee is best known for codifying the TNM system in coordination with Union for International Cancer Control, International Association for the Study of Lung Cancer, Breast Cancer Research Foundation, and specialist consensus panels from American Urological Association, American Gastroenterological Association, American Thoracic Society, and American Academy of Otolaryngology–Head and Neck Surgery. Key contributions incorporated evidence from trials at European Organisation for Research and Treatment of Cancer, Gynecologic Oncology Group, Radiation Therapy Oncology Group, and translational research from laboratories at Cold Spring Harbor Laboratory and Sloan Kettering Institute. Updates reflect staging biomarkers validated in studies published by investigators at Fred Hutchinson Cancer Research Center, Scripps Research Institute, Johns Hopkins Bloomberg School of Public Health, and consortia such as The Cancer Genome Atlas and Human Genome Project-related initiatives.

Publications and Guidelines

The AJCC issues editions of a staging manual produced with publishers and professional societies, referenced by journals including Journal of Clinical Oncology, Cancer, Lancet Oncology, and specialty titles such as Annals of Surgical Oncology and European Journal of Cancer. Guidelines integrate recommendations from panels involving National Comprehensive Cancer Network, American Association for Cancer Research, American Society of Clinical Pathology, and subspecialty groups like Society of Gynecologic Oncology and American Urological Association Foundation. Educational supplements and modules have been disseminated via conferences at American Society of Clinical Oncology Annual Meeting, Radiological Society of North America, European Society for Medical Oncology Congress, and workshops hosted by Memorial Sloan Kettering Cancer Center.

Educational and Research Activities

Training programs and symposia collaborate with academic centers including University of Pennsylvania Perelman School of Medicine, Boston Children's Hospital, Vanderbilt University Medical Center, Emory University School of Medicine, and University of California, Los Angeles David Geffen School of Medicine. Research initiatives coordinate registry analyses with National Program of Cancer Registries, observational cohorts such as Framingham Heart Study-linked projects, and outcomes research supported by foundations like Bill & Melinda Gates Foundation and Susan G. Komen. The committee convenes working groups drawing experts from Royal College of Physicians, Karolinska Institutet, University of Toronto, Peking University Cancer Hospital, and Seoul National University Hospital to develop educational curricula, certification modules, and research agendas.

Impact and Criticism

The staging systems influenced clinical pathways at institutions like Cleveland Clinic Foundation, Mount Sinai Health System, Kaiser Permanente, and informed policy at agencies such as Centers for Medicare & Medicaid Services and World Health Organization. Critiques have come from investigators at University College London, University of Oxford, McGill University, and specialty societies noting limitations in applicability to rare tumors, disparities highlighted by researchers at Johns Hopkins Bloomberg School of Public Health and Columbia University Mailman School of Public Health, and calls for integration with molecular classifiers advanced by Broad Institute, Wellcome Trust Sanger Institute, and European Molecular Biology Laboratory. Debates have occurred at meetings featuring contributors from American Society of Clinical Oncology, International Agency for Research on Cancer, and patient advocacy groups such as LIVESTRONG Foundation and American Cancer Society Cancer Action Network.

Category:Cancer organizations